# An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

> **NCT02365623** · PHASE2 · COMPLETED · sponsor: **Janssen Pharmaceutical K.K.** · enrollment: 6 (actual)

## Conditions studied

- Tuberculosis, Multidrug-Resistant

## Interventions

- **DRUG:** TMC207 (bedaquiline)
- **DRUG:** Background Regimen (BR)

## Key facts

- **NCT ID:** NCT02365623
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-18
- **Primary completion:** 2018-11-08
- **Final completion:** 2018-11-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365623, "An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02365623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*